2 completed. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow enisamium iodide: new trials by email Literature Review of enisamium iodide trials Research Report on enisamium iodide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study to Assess the Efficacy and Safety of Amizon® Max in the Treatment of Moderate Covid-19, Caused by the SARS-CoV-2 Virus Enisamium Iodide, Placebo - Covid-19 Disease | Phase 3 | Completed | Joint Stock Company "Farmak" | 592 | 2020-05-15 | 2021-12-29 |
| Efficacy and Safety of Enisamium Iodide for the Treatment of Acute Respiratory Viral Infections, Including Influenza. Enisamium Iodide, Placebo - Acute Respiratory Viral Infections, Human Influenza | Phase 2 / Phase 3 | Completed | Joint Stock Company "Farmak" | 100 | 2009-04-13 | 2026-01-08 |
COVID-19 (1) · Influenza, Human (1) · Virus Diseases (1)
Joint Stock Company "Farmak" (2)
Ukraine (1)
Ekatarina A. Okhapkina (1) · Olha Holubovska, MD, DSc (1)